{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:35:52Z","timestamp":1785465352239,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s10689-012-9519-5","type":"journal-article","created":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T14:40:56Z","timestamp":1330526456000},"page":"351-354","source":"Crossref","is-referenced-by-count":19,"title":["Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases"],"prefix":"10.1007","volume":"11","author":[{"given":"Izabela","family":"Brozek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Ratajska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Piatkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kluska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Balabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalina","family":"Dabrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Nowakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Niwinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Rachtan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Limon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,1]]},"reference":[{"issue":"8","key":"9519_CR1","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1200\/JCO.2008.17.5869","volume":"27","author":"D Huo","year":"2009","unstructured":"Huo D, Senie RT, Daly M et al (2009) Prediction of BRCA mutations using the BRCAPRO model in clinic-based African American, hispanic and other minority families in the United States. J Clin Oncol 27(8):1184\u20131190","journal-title":"J Clin Oncol"},{"issue":"5645","key":"9519_CR2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB, New York Breast Cancer Study Group (2003) Breast and ovarian cancer risk due to inherited mutation in BRCA1 and BRCA2. Science 302(5645):643\u2013646","journal-title":"Science"},{"issue":"23","key":"9519_CR3","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario. Can J Natl Cancer Inst 98(23):1694\u20131706","journal-title":"Can J Natl Cancer Inst"},{"issue":"3","key":"9519_CR4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.2009.25.0712","volume":"28","author":"KA Metcalfe","year":"2010","unstructured":"Metcalfe KA, Poll A, Royer R et al (2010) Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. J Clin Oncol 28(3):387\u2013391","journal-title":"J Clin Oncol"},{"issue":"3","key":"9519_CR5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13353-011-0040-6","volume":"52","author":"I Brozek","year":"2011","unstructured":"Brozek I, Cybulska C, Ratajska M et al (2011) Prevalence of the most frequent BRCA1 mutations in Polish population. J Appl Genet 52(3):325\u2013330","journal-title":"J Appl Genet"},{"issue":"1","key":"9519_CR6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/1098-1004(2001)17:1<75::AID-HUMU15>3.0.CO;2-9","volume":"17","author":"A Jasinska","year":"2001","unstructured":"Jasinska A, Krzyzosiak WJ (2001) Prevalence of BRCA1 founder mutations in western Poland. Hum Mutat 17(1):75","journal-title":"Hum Mutat"},{"issue":"6","key":"9519_CR7","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1086\/302922","volume":"66","author":"B Gorski","year":"2000","unstructured":"Gorski B, Byrski T, Huzarski T et al (2000) Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet 66(6):1963\u20131968","journal-title":"Am J Hum Genet"},{"issue":"1","key":"9519_CR8","first-page":"263","volume":"19","author":"M Ratajska","year":"2008","unstructured":"Ratajska M, Brozek I, Senkus-Konefka E et al (2008) BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland. Oncol Rep 19(1):263\u2013268","journal-title":"Oncol Rep"},{"issue":"5","key":"9519_CR9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/humu.9139","volume":"21","author":"M Perkowska","year":"2003","unstructured":"Perkowska M, Brozek I, Wysocka B et al (2003) BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from north-eastern Poland. Hum Mutat 21(5):553\u2013554","journal-title":"Hum Mutat"},{"key":"9519_CR10","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<480::AID-HUMU13>3.0.CO;2-G","volume":"15","author":"M Looij Van Der","year":"2000","unstructured":"Van Der Looij M, Wysocka B, Brozek I et al (2000) Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and\/or ovarian cancer families from North-Eastern Poland. Hum Mutat 15:480\u2013487","journal-title":"Hum Mutat"},{"issue":"6","key":"9519_CR11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/1098-1004(200012)16:6<482::AID-HUMU5>3.0.CO;2-O","volume":"16","author":"E Grzybowska","year":"2000","unstructured":"Grzybowska E, Zientek H, Jasinska A et al (2000) High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer. Hum Mutat 16(6):482\u2013490","journal-title":"Hum Mutat"},{"issue":"6","key":"9519_CR12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1399-0004.2003.00178.x","volume":"64","author":"H Janiszewska","year":"2003","unstructured":"Janiszewska H, Haus O, Lauda-Swieciak A et al (2003) Frequency of three BRCA1 gene founder mutations in breast\/ovarian cancer families from the Pomerania-Kujawy region of Poland. Clin Genet 64(6):502\u2013508","journal-title":"Clin Genet"},{"issue":"12","key":"9519_CR13","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.2078.13.12","volume":"13","author":"AS Whittemore","year":"2004","unstructured":"Whittemore AS, Gong G, John EM et al (2004) Prevalence of BRCA1 mutation carriers among U.S. non-Hispanic Whites. Cancer Epidemiol Biomarkers Prev 13(12):2078\u20132083","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"9519_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10549-005-1409-1","volume":"92","author":"B Gorski","year":"2005","unstructured":"Gorski B, Cybulski C, Huzarski T et al (2005) Breast cancer predisposing alleles in Poland. Breast Cancer Res Treat 92(1):19\u201324","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"9519_CR15","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.1158\/0008-5472.CAN-06-0503","volume":"66","author":"KE Malone","year":"2006","unstructured":"Malone KE, Daling JR, Doody DR et al (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women, ages 35 to 64\u00a0years. Cancer Res 66(16):8297\u20138308","journal-title":"Cancer Res"},{"issue":"10","key":"9519_CR16","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ejca.2006.01.050","volume":"42","author":"AP Sokolenko","year":"2006","unstructured":"Sokolenko AP, Mitiushkina NV, Buslov KG et al (2006) High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer 42(10):1380\u20131384","journal-title":"Eur J Cancer"},{"issue":"24","key":"9519_CR17","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1001\/jama.298.24.2869","volume":"298","author":"EM John","year":"2007","unstructured":"John EM, Miron A, Gong G et al (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial\/ethnic groups. JAMA 298(24):2869\u20132876","journal-title":"JAMA"},{"issue":"1","key":"9519_CR18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/GCO.0b013e328332dca3","volume":"22","author":"EM John","year":"2010","unstructured":"John EM (2010) BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 22(1):72\u201378","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"23","key":"9519_CR19","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.297.23.2587","volume":"297","author":"JN Weitzel","year":"2007","unstructured":"Weitzel JN, Lagos VI, Cullinane CA et al (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297(23):2587\u20132595","journal-title":"JAMA"},{"issue":"26","key":"9519_CR20","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1200\/JCO.2008.16.6231","volume":"26","author":"DP Atchley","year":"2008","unstructured":"Atchley DP, Albarracin CT, Lopez A et al (2008) Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 26(26):4282\u20134288","journal-title":"J Clin Oncol"},{"issue":"4","key":"9519_CR21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1200\/JCO.2005.01.9737","volume":"24","author":"PA James","year":"2006","unstructured":"James PA, Doherty R, Harris M et al (2006) Optimal selection of individuals for BRCA mutation testing: a comparison of available methods. J Clin Oncol 24(4):707\u2013715","journal-title":"J Clin Oncol"},{"issue":"4","key":"9519_CR22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10689-010-9362-5","volume":"9","author":"AC Vargas","year":"2010","unstructured":"Vargas AC, Silva LD, Lakhani SR (2010) The contribution of breast cancer pathology to statistical models to predict mutation risk in BRCA carriers. Fam Cancer 9(4):545\u2013553","journal-title":"Fam Cancer"},{"issue":"2","key":"9519_CR23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ygyno.2007.09.035","volume":"108","author":"I Brozek","year":"2008","unstructured":"Brozek I, Ochman K, Debniak J et al (2008) High frequency of BRCA1\/2 germline mutations in consecutive ovarian cancer patients in Poland. Gynecol Oncol 108(2):433\u2013437","journal-title":"Gynecol Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10689-012-9519-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T21:05:24Z","timestamp":1687295124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-012-9519-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["9519"],"URL":"https:\/\/doi.org\/10.1007\/s10689-012-9519-5","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,1]]}}}